Moderna says it has the capacity to deliver one billion doses of COVID-19 vaccine, mRNA-1273 but is concerned with raw material supply. Moderna has an approved vaccine for COVID-19 in the US, Europe and UK. Speaking at the 39th Annual JP Morgan virtual Healthcare Conference, CEO Stéphane Bancel highlighted how potential shortages of material could delay manufacture despite Moderna “structuring the company to deliver a billion doses†in a year. “I think sometimes people confuse capacity and supply†said Bancel,…
Thursday, January 14, 2021 Daily Archives
Pall investing $114m, adding 1,100 jobs, on back of COVID single-use demand
Pall Corporation will invest $114 million to increase global production capacity for single-use bioprocessing systems in response to COVID-19 related demand. The firm will add capacity at its facilities in Medemblik in the Netherlands, Hoegaarden in Belgium, Bad Kreuznach in Germany, Ilfracombe and Newquay in the UK, Fajardo in Puerto Rico, and Pensacola in the US. Pall cited “industry demands driven by COVID-19†as the driver for the investment adding that it expects to create 1,100 jobs globally now through…